Evidence map›Paper›PMID 36062444›Full record

ArticleTurkish archives of pediatrics2022

Kidney Involvement in Pediatric COVID-19 Cases: A Single-Center Experience.

Ayşe Ağbaş, Gülşen Akkoç, Cevher Kızılırmak, Nurcihan Çalışkan Dolu, Elvan Bayramoğlu, Murat Elevli

Open access · diamondAbstract read
In one paragraph

Article in Turkish archives of pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Ayşe AğbaşDepartment of Pediatric Nephrology, University of Health Sciences, Haseki Training and Research Hospital, İstanbul, Turkey; Department of Pediatric Nephrology, İstanbul University -Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Turkey.
Gülşen AkkoçDepartment of Pediatric Infectious Diseases, University of Health Sciences, Haseki Training and Research Hospital, İstanbul, Turkey.
Cevher KızılırmakDepartment of Pediatrics, University of Health Sciences, Haseki Training and Research Hospital, İstanbul, Turkey.
Nurcihan Çalışkan DoluDepartment of Biochemistry, University of Health Sciences, Haseki Training and Research Hospital, İstanbul, Turkey.
Elvan BayramoğluDepartment of Pediatric Endocrinology, University of Health Sciences, Haseki Training and Research Hospital, İstanbul, Turkey; Department of Pediatric Endocrinology, İstanbul University -Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Turkey.
Murat ElevliDepartment of Pediatrics, University of Health Sciences, Haseki Training and Research Hospital, İstanbul, Turkey.
Haseki Eğitim ve Araştırma Hastanesi · TRIstanbul University-Cerrahpaşa · TRUniversity of Health Science · KH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe kidney is the second most commonly affected organ by severe acute respiratory syndrome coronavirus-2, characterized by hematuria, proteinuria, and acute kidney injury. There are few studies describing renal involvement in pediatric cases. MATERIALS AND

methodsThis retrospective study evaluated the prevalence of hematuria, proteinuria, and acute kidney injury in severe acute respiratory syndrome coronavirus-2-positive pediatric cases (1-18 years old) who visited emergency department between March and November 2020. Patients with urinary tract infections were excluded. An age-specific upper limit of reference interval was used to define "elevated serum creatinine" (greater than upper limit of reference interval) and acute kidney injury (>1.5 times upper limit of reference interval).

resultsA total of 228 patients were evaluated, median age was 12.7 years (interquartile range: 7.5; 16.1), and 51.3% were male. The prevalence of asymptomatic, mild, and moderate-to-severe disease was 12.7% (29/228), 77.2% (176/228), and 10.1% (23/228), respectively. The prevalence of hematuria, proteinuria, and elevated serum creatinine was 15.8% (36/228), 6% (14/228), and 3% (7/228), respectively. Kidney involvement (i.e., at least 1 of these findings) was 23.2% (53/228) and significantly higher in the moderate-to-severe disease (43.5%). None of the patients met the acute kidney injury criterion. In logistic regression analysis, female sex (odds ratio: 1.97, 95 CI%: 1.03; 3.70, P = .040) and fever (odds ratio: 2.28, 95% CI: 1.19; 4.36, P = .012) were independent predictors of kidney involvement. Three patients demonstrated a kidney presentation (macroscopic hematuria) on admission, and another patient was diagnosed with C3 glomerulonephritis during hospitalization.

conclusionKidney involvement was found about in 1 quarter of children with coronavirus disease 2019. Awareness and recognition of kidney involvement and follow-up are important in the management.

Identifiers

PMID36062444
PMCPMC9524429
OpenAlexW4294169848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.